prematur
infant
suffer
signific
respiratori
morbid
infanc
longterm
neg
consequ
health
qualiti
life
health
care
cost
enhanc
suscept
varieti
infect
inflamm
play
larg
role
earli
prolong
lung
diseas
follow
prematur
birth
though
mechan
suscept
immun
dysregul
activ
area
research
chapter
review
aspect
hostpathogen
interact
immun
respons
alter
preterm
birth
impact
chronic
respiratori
morbid
children
prematur
neonat
immunolog
neonat
infect
viru
lymphocyt
bronchopulmonari
dysplasia
chronic
lung
diseas
prematur
preterm
year
approxim
infant
unit
state
babi
yearli
born
prematur
week
gestat
infant
suffer
complic
exposur
divers
environ
time
develop
respiratori
tract
immun
system
intend
protect
maintain
rel
intrauterin
state
infanc
earli
childhood
prematur
infant
suffer
signific
inflammatori
infecti
respiratori
morbid
extend
neg
consequ
health
qualiti
life
health
care
cost
compar
approxim
full
term
newborn
latepreterm
lpt
born
week
earli
preterm
infant
ept
born
week
rehospit
within
first
year
life
commonli
viral
respiratori
infect
respiratori
infect
less
sever
requir
hospit
even
common
recurr
total
costli
young
incid
sever
respiratori
tract
infect
babi
less
one
year
age
attribut
least
part
immun
immatur
problem
magnifi
preterm
birth
influenc
genet
trait
environment
exposur
differ
gastrointestin
tract
colon
pattern
develop
balanc
intestin
microbiom
shown
influenc
immunolog
develop
full
term
infant
begun
evalu
prematur
viral
infect
either
subclin
sever
may
also
alter
immunolog
develop
directli
alter
bacteri
microflora
preterm
babi
expos
matern
hospitalbas
flora
frequent
addit
pressur
antibiot
indwel
cathet
tube
alter
establish
divers
health
promot
microbiota
skin
respiratori
mucosa
well
gastrointestin
tract
increas
risk
invas
diseas
predomin
organ
recurr
respiratori
symptom
first
year
life
correl
invers
gestat
age
birth
directli
utero
exposur
inflamm
chorioamnion
nonwhit
race
pathogenesi
chronic
lung
diseas
prematur
bronchopulmonari
dysplasia
recent
review
close
correl
utero
inflamm
oxygen
toxic
ventilatorinduc
trauma
prealveolar
lung
develop
birth
figur
prematur
birth
induc
slow
arrest
lung
develop
underli
bpd
like
occur
spectrum
sever
prematur
born
infant
perinat
therapeut
environment
exposur
notabl
oxygen
exposur
environment
tobacco
smoke
reproduc
relat
chronic
respiratori
morbid
independ
mechan
ventil
diagnosi
bpd
recent
studi
low
birth
weight
vlbw
infant
without
bpd
demonstr
signific
relationship
integr
estim
oxygen
exposur
first
day
life
symptomat
respiratori
diseas
srd
first
year
life
lower
gestat
age
nonwhit
race
greater
oxygen
exposur
chorioamnion
significantli
increas
odd
ratio
infant
srd
recent
murin
model
demonstr
earli
neonat
exposur
hyperoxia
dramat
increas
doserespons
manner
sever
influenza
infect
induc
adulthood
markedli
enhanc
inflamm
fibrot
repair
observ
increas
understand
preterm
infant
immun
system
well
exposur
colon
infect
microorgan
suggest
intervent
modifi
immunolog
respons
may
significantli
improv
respiratori
gener
outcom
children
chapter
review
prenat
postnat
exposur
induc
lung
inflamm
preterm
infant
context
uniqu
suscept
factor
occur
prematur
deliveri
sever
line
evid
suggest
inflammatori
respons
fetal
prematur
lung
injuri
infect
caus
diseas
exacerb
sever
chronic
lung
diseas
infant
risk
recent
review
highlight
current
understand
role
inflammatori
mediat
immunobiolog
bpd
increas
level
proinflammatori
mediat
amniot
fluid
earli
tracheal
effluent
lung
tissu
serum
atrisk
prematur
infant
support
role
intrauterin
extrauterin
inflamm
develop
sever
bpd
airway
bronchoalveolar
lavag
sampl
demonstr
increas
inflammatori
cell
multipl
proinflammatori
mediat
ventil
oxygenexpos
infant
progress
toward
bpd
genomewid
express
profil
bpd
lung
compar
gestat
age
match
control
identifi
differenti
express
gene
pathway
analysi
identifi
cell
cycl
immunodefici
signal
b
cell
develop
pathway
associ
bpd
addit
top
differenti
express
gene
set
relat
chymas
express
mast
cell
presenc
confirm
pcr
immunohistochemistri
consist
activ
inflamm
transcript
factor
prototyp
regul
inflamm
cell
surviv
elev
neutrophil
macrophag
preterm
infant
airway
correl
presenc
u
urealyticum
need
prolong
mechan
ventil
interestingli
activ
fetal
lung
fetal
lung
macrophag
shown
inhibit
airway
morphogenesi
activ
fibroblast
growth
factor
critic
factor
lung
develop
link
inflamm
growth
arrest
preterm
lung
sever
anim
model
demonstr
mediat
inflamm
includ
endotoxin
tumor
necrosi
factor
transform
growth
factor
enhanc
lung
matur
also
impair
alveolar
septat
vascular
remodel
thu
contribut
develop
bpd
even
without
frank
tissu
destruct
proinflammatori
stimuli
come
multipl
sourc
prematur
infant
prenat
birth
common
caus
consid
next
thought
steril
modern
molecular
techniqu
independ
cultur
demonstr
amniot
fluid
placent
tissu
frequent
contain
microb
maternalfet
inflamm
clinic
identifi
chorioamnion
matern
fever
one
maternalfet
tachycardia
matern
leukocytosi
uterin
tender
andor
foul
amniot
fluid
recent
studi
util
amniocentesi
sampl
amniot
fluid
mother
sign
symptom
clinic
chorioamnion
detect
microorgan
cultur
andor
polymeras
chain
reactionmass
spectrometri
frequent
one
microb
fifteen
percent
neither
inflamm
infect
amniot
fluid
evid
inflamm
without
detect
microorgan
suggest
noninfecti
caus
clinic
symptom
clinic
chorioamnion
also
histolog
evid
placent
inflamm
sever
acut
histolog
chorioamnion
correl
amniot
fluid
level
support
presenc
activ
inflamm
uncommon
howev
evid
acut
histolog
chorioamnion
without
detect
microorgan
rang
caus
steril
inflamm
fetalplacent
tissu
may
noninfecti
diseas
lack
sensit
microbi
detect
inflammatori
placent
lesion
chronic
form
character
lymphocyt
plasma
cell
macrophag
sometim
eosinophil
also
occur
associ
preterm
birth
recurr
placent
failur
frequent
lesion
unknown
etiolog
chorioamnion
associ
chronic
lung
diseas
prematur
multipl
small
seri
focus
studi
specif
organ
ureaplasma
experiment
model
chorioamnion
caus
intraamniot
inject
endotoxin
ureaplasma
initi
caus
fetal
lung
inflamm
follow
persist
lowgrad
inflamm
evid
enhanc
lung
matur
aggress
inflammatori
respons
oxygen
mechan
ventil
newborn
histori
chorioamnion
suggest
anim
model
clinic
report
sever
fetal
inflammatori
respons
infect
indic
amniot
fluid
invers
relat
gestat
age
suggest
prematur
infant
greater
risk
inflammatori
injuri
common
organ
isol
infect
amniot
fluid
placenta
u
parvum
u
urealyticum
likewis
rel
common
identifi
organ
bodili
fluid
preterm
infant
compel
evid
associ
pulmonari
ureaplasma
colon
bronchopulmonari
dysplasia
preterm
infant
recent
review
detail
discuss
clinic
trial
treatment
ureaplasma
found
respiratori
secret
preterm
infant
review
chapter
xx
journal
howev
role
chorioamnion
risk
factor
bpd
remain
controversi
recent
debat
sever
larg
studi
question
relationship
utero
infect
chronic
lung
diseas
part
elgan
studi
exhaust
placent
bacteri
cultur
done
deliveri
week
gestat
correl
placent
cultur
result
phenotyp
infant
assess
oxygen
need
day
life
develop
bpd
canadian
neonat
network
also
report
infant
born
gestat
expos
clinic
chorioamnion
increas
incid
bpd
lahra
et
al
report
use
year
experi
sydney
fetal
inflammatori
respons
protect
bpd
similar
studi
demonstr
clinic
cultur
proven
chorioamnion
good
predictor
bpd
chorioamnionitisinfect
major
associ
preterm
prematur
ruptur
membran
preterm
labor
earli
gestat
also
chorioamnion
associ
inflamm
lung
preterm
infant
soon
birth
caus
lung
inflamm
alter
immun
modul
anim
model
type
durat
fetal
exposur
control
clinic
variat
detect
virul
caus
organ
well
durat
infect
maternalfet
inflammatori
respons
complic
determin
effect
outcom
assess
influenc
preterm
infant
chronic
lung
diseas
confound
imprecis
diagnosi
bpd
outlin
figur
number
maternalfetalplacent
abnorm
alter
lung
growth
andor
induc
fetal
inflamm
associ
matern
preeclampsia
placent
insuffici
associ
intrauterin
growth
restrict
bpd
howev
remain
controversi
studi
suggest
increas
other
decreas
effect
antenat
corticosteroid
enhanc
fetal
lung
matur
like
reduc
inflamm
although
one
studi
suggest
corticosteroid
reduc
bpd
histolog
chorioamnion
littl
effect
rate
bpd
mani
exposur
postnat
period
promot
inflamm
oxygen
mechan
ventil
togeth
independ
induc
inflamm
via
direct
cellular
injuri
induct
cytokin
chemokin
recruit
neutrophil
macrophag
oxid
dna
lipid
protein
oxygen
toxic
barotrauma
volutrauma
import
hazard
mechan
ventil
associ
releas
inflammatori
cytokin
chemokin
caus
pulmonari
injuri
higher
level
cytokin
correl
prolong
durat
ventil
supplement
oxygen
also
contribut
inflamm
biochem
pathway
oxid
stress
sepsi
beyond
first
day
life
frequent
elbw
infant
risk
bpd
often
present
respiratori
instabl
earli
late
microbi
presenc
neonat
lung
fluid
sampl
significantli
associ
develop
chronic
lung
diseas
suggest
anteand
postnat
infect
play
role
develop
diseas
numer
studi
associ
postnat
sepsi
earlyand
lateonset
typic
common
infecti
agent
coagulas
neg
staphylococcu
gramneg
bacteria
bpd
suggest
sepsisinduc
inflamm
compromis
lung
develop
heal
administr
intraven
immunoglobulin
howev
although
associ
small
reduct
sepsi
shown
metaanalysi
random
control
trial
reduc
incid
bpd
broad
respiratori
viru
surveil
nicu
rel
new
approach
augment
readili
avail
cultureindepend
method
detect
previou
nicu
viral
studi
target
patient
threshold
symptom
approach
small
pandem
viral
infect
adenoviru
respiratori
syncyti
viru
rsv
detect
overal
infect
rate
nicu
appear
rel
low
exampl
use
symptom
base
test
strategi
viral
infect
confirm
infant
admit
nicu
enteroviru
parechoviru
infect
rsv
rotaviru
cytomegaloviru
cmv
adenoviru
parainfluenza
viru
herp
simplex
viru
rhinoviru
rubella
viru
recent
data
includ
collect
expedit
autopsi
human
neonat
distal
lung
tissu
suggest
rel
high
preval
lung
viral
infect
succumb
respiratori
failur
nicu
sampl
test
viru
posit
data
shown
coronaviru
rhinoviru
parainfluenza
cmv
detect
rtpcr
interestingli
small
postmortem
sampl
rsv
influenza
b
parainfluenza
type
metapneumoviru
detect
surveil
studi
util
pcr
genom
sequenc
detect
begun
report
closer
true
incid
nosocomi
viral
respiratori
infect
nvri
neonat
children
hospit
pediatr
neonat
intens
care
unit
nicu
surveil
studi
nasal
brush
sampl
taken
weekli
neonat
age
day
children
age
day
hospit
winter
viral
season
total
patient
enrol
neonat
children
patient
viru
posit
pcr
incid
seven
posit
sampl
human
coronavirus
detect
incid
risk
factor
nvri
neonat
durat
hospit
antibiot
treatment
durat
parenter
nutrit
p
oneyear
nicu
surveil
studi
infant
born
week
gestat
use
pcr
detect
viral
subtyp
identifi
least
one
posit
respiratori
viru
hospit
subject
asymptomat
test
posit
associ
longer
length
stay
length
mechan
ventil
well
diagnosi
bpd
similar
ongo
studi
determin
viral
infect
common
occurr
nicu
warrant
frequent
surveil
develop
intervent
reduc
exposur
ill
human
cytomegaloviru
cmv
betaherpesvirina
viru
latent
leukocyt
highli
preval
human
popul
approxim
adult
cmv
seroposit
mother
preterm
infant
congenit
utero
infect
fetu
occur
pregnanc
may
aris
primari
infect
mother
reactiv
pregnanc
latent
infect
reinfect
differ
strain
cmv
postnat
viru
spread
even
effici
mother
newborn
via
breastmilk
sinc
reactiv
cmv
seroposit
women
postpartum
period
detect
breastmilk
earli
day
deliveri
cmv
rel
common
viral
infect
newborn
period
transmiss
full
term
newborn
report
approxim
preterm
infant
vari
potenti
due
differ
strain
use
freshfrozen
milk
matern
factor
affect
viral
shed
surveil
studi
nicu
neonat
test
serum
cmvtiter
cmvdna
demonstr
overal
preval
cmv
ten
infant
congenit
infect
case
perinat
infect
postnat
infect
newborn
detect
molecular
diagnost
earli
day
life
infect
remain
clinic
silent
major
postnatali
infect
low
birth
weight
preterm
infant
report
demonstr
sever
sepsislik
infect
although
lower
gestat
age
infant
increas
risk
develop
symptom
postnat
infect
also
greatest
risk
bronchopulmonari
dysplasia
remain
rel
littl
evid
caus
effect
prosch
et
al
found
approxim
vlbw
infant
bpd
cmv
posit
without
bpd
studi
other
found
postnat
infect
symptom
preterm
transient
effect
neonat
outcom
includ
bpd
necrot
enterocol
review
pubm
paper
describ
cmv
pneumon
howev
conclud
cmv
infect
protract
diffus
interstiti
pneumon
associ
fibrosi
bpd
would
appear
surveil
outcom
studi
need
determin
caus
relationship
exist
anticmv
therapi
method
reduc
transmiss
cmv
fetu
neonat
could
effect
reduc
diseas
interestingli
cmv
notabl
influenc
human
immun
system
induc
substanti
cytolyt
cell
popul
cmv
infect
infant
induc
differenti
phenotyp
matur
cell
also
function
activ
cell
produc
interferon
gamma
upon
restimul
serum
cytokin
concentr
measur
cmv
congenit
infect
infant
show
evid
strong
bia
predomin
product
diminish
sinc
gener
secret
cell
effector
cell
associ
success
recoveri
viral
infect
gener
rsv
particular
data
suggest
cmv
infect
infanc
could
benefici
howev
concern
cmvinduc
immunoag
lymphocyt
may
ultim
result
immunosuppress
suggest
poor
vaccin
respons
elderli
recurr
wheez
later
childhood
associ
infect
respiratori
syncyti
viru
rsv
metapneumoviru
hmpv
parainfluenza
piv
rhinoviru
human
coronaviru
rsv
infect
best
demonstr
effect
viral
respiratori
tract
infect
infanc
may
longliv
prematur
infant
born
less
week
gestat
without
bpd
histori
rsv
lrti
found
day
cough
wheez
one
year
age
without
rsv
lrti
addit
rsv
lrti
hmpv
lrti
found
increas
airway
resist
one
year
age
pulmonari
function
test
infant
airway
function
shown
deterior
first
year
life
group
bpd
follow
school
entri
hospit
rsv
lrti
anoth
respiratori
ill
within
first
two
year
life
greater
cumul
number
outpati
visit
cost
care
compar
former
prematur
infant
bpd
without
respiratori
hospit
subset
children
pulmonari
function
test
year
age
demonstr
significantli
reduc
lung
function
lower
forc
expiratori
volum
vital
capac
flow
vital
capac
rsv
lrti
compar
children
without
whether
viral
lrti
caus
subsequ
airway
diseas
mere
marker
preexist
abnorm
lung
function
definit
determin
role
atopi
predisposit
asthma
postinfect
airway
remodel
relationship
lrti
subsequ
wheez
childhood
also
clear
combin
viral
factor
innat
adapt
immun
respons
set
suscept
genet
background
young
elderli
host
appear
drive
clinic
outcom
ongo
studi
prematur
infant
viral
lrti
includ
baselin
pulmonari
function
test
seek
determin
viral
respiratori
infect
causal
increas
longterm
morbid
mere
marker
children
sever
preexist
lung
diseas
suggest
term
infant
clinicaltrialsgov
question
import
evalu
select
vaccin
strategi
prevent
sever
lrti
chronic
diseas
immun
system
doubleedg
sword
littl
respons
microb
invad
injur
robust
host
respons
may
result
bystand
injuri
diseas
addit
exposur
infecti
agent
appear
certain
intrins
factor
result
enhanc
inflammatori
respons
individu
adult
child
preterm
infant
compar
other
evid
suggest
preterm
infant
may
affect
rel
immunosuppress
robust
immun
respons
full
term
infant
conclud
chapter
review
suscept
factor
identifi
suggest
enhanc
inflamm
prematur
born
genet
predispos
shorten
pregnanc
especi
relat
increas
inflamm
natur
increas
risk
inflammatori
lung
diseas
prematur
exampl
elev
midtrimest
vagin
associ
increas
risk
spontan
preterm
birth
homozyg
carrier
singl
nucleotid
polymorph
receptor
antagonist
gene
genotyp
associ
elev
increas
risk
preterm
birth
exampl
genet
polymorph
affect
innat
immun
system
risk
prematur
women
preterm
birth
combin
clinic
chorioamnion
g
allel
associ
increas
risk
deliveri
week
gestat
suggest
geneenviron
interact
infant
twin
studi
suggest
signific
genet
suscept
bpd
rel
inflamm
genotyp
analysi
multipl
comparison
correct
reveal
two
signific
singlenucleotid
polymorph
snp
african
american
aa
bpd
vs
aa
without
bpd
q
associ
caucasian
ca
bpd
aa
ca
respiratori
distress
syndrom
rd
prematur
either
aa
ca
identifi
snp
function
polymorph
promot
nfkbia
encod
neg
regul
associ
differenti
suscept
sever
bronchopulmonari
dysplasia
well
common
inflammatori
diseas
infant
lung
number
addit
studi
evalu
exom
sequenc
extrem
diseas
epigenom
regul
transcriptom
respons
exposur
hyperoxia
pathway
analys
ongo
identifi
gene
gene
regulatori
suscept
factor
involv
pathogenesi
bpd
recent
develop
miniatur
technolog
includ
assay
base
polychromat
flow
cytometri
multiplex
protein
assay
lowinput
transcript
analys
begun
advanc
field
neonat
immunolog
dowl
levi
provid
recent
review
vivo
vitro
approach
studi
earlylif
immunodevelop
well
summari
uniqu
characterist
preterm
term
innat
adapt
immun
system
innat
immun
respons
full
term
infant
includ
function
recruit
granulocyt
natur
killer
nk
cell
antigen
present
cell
character
immatur
function
suppress
innat
immun
respons
human
preterm
infant
less
well
character
fetal
cell
includ
nk
cell
enhanc
sensit
immunosuppress
effect
tgf
beta
earli
life
antigen
present
cell
tend
produc
predominantli
immunosuppress
cytokin
intriguingli
recent
studi
addit
suggest
nucleat
red
blood
cell
erythroid
precursor
cell
typic
increas
fetal
blood
especi
pregnanc
complic
placent
insuffici
appear
suppress
phagocyt
antigen
present
cell
stimulusinduc
tnf
alpha
product
suggest
immunosuppress
function
lymphocyt
adapt
immun
system
provid
critic
defens
intracellular
includ
viral
infect
reduc
cell
result
impair
immun
respons
pathogen
cell
nk
cell
provid
protect
viral
infect
also
contribut
immunopatholog
contactdepend
effector
function
ex
perforin
fasl
particularli
thought
primari
perpetr
tcellmedi
lung
injuri
yet
also
import
antimicrobi
defens
fetal
neonat
period
uniqu
immun
development
stage
adapt
respons
highli
plastic
depend
gestat
age
although
rel
littl
literatur
refer
detail
phenotyp
lymphocyt
matur
prematur
born
infant
investig
numer
evalu
class
lymphocyt
human
fetu
young
child
total
circul
white
cell
count
increas
latter
half
gestat
term
deliveri
decreas
slightli
adult
level
percentag
lymphocyt
decreas
approxim
median
term
deliveri
adult
human
base
cord
blood
sampl
deliveri
cordocentesi
proport
cell
howev
increas
gestat
age
presenc
infect
normal
pregnanc
circul
cell
number
invers
relat
gestat
age
fetal
percentag
cell
reduc
increas
term
ratio
also
vari
invers
gestat
age
higher
verylowbirthweight
vlbw
infant
fullterm
matern
diseas
may
alter
fetal
lymphocyt
preeclampsia
signific
effect
cell
distribut
associ
fewer
cell
doubleposit
cell
decreas
ratio
reduc
regulatori
cell
subset
cord
blood
matern
betamethason
therapi
also
associ
higher
cell
proport
lower
proport
nk
cell
sever
line
investig
suggest
role
dysregul
respons
bpd
anim
model
cell
accumul
lung
preterm
lamb
expos
lp
utero
preterm
baboon
develop
bpd
found
abund
cell
lung
parenchyma
signific
infiltr
cell
note
distal
lung
infant
die
bpd
compar
gestat
age
match
without
lung
diseas
serial
blood
sampl
prematur
infant
rd
born
gestat
ballabh
et
al
demonstr
reduct
absolut
lymphocyt
count
well
percentag
absolut
number
cell
progress
bpd
p
signific
even
day
one
life
activ
cell
go
develop
bpd
may
reflect
sequestr
activ
cell
within
lung
cell
percentag
continu
decreas
postnat
age
berrington
et
al
measur
lymphocyt
subclass
prematur
infant
prior
first
immun
week
age
prematur
born
infant
lower
absolut
lymphocyt
cell
b
cell
helper
cell
count
lower
cell
ratio
term
infant
well
increas
proport
treg
cell
decreas
cell
month
b
cell
popul
numer
normal
cell
abnorm
persist
recent
studi
challeng
concept
cell
respons
uniformli
impair
neonat
especi
preterm
infant
although
major
newborn
cell
activ
marker
like
enhanc
cell
prematur
born
infant
likewis
proport
cord
blood
cell
suggest
activ
also
higher
lower
gestat
age
sever
report
demonstr
correl
cell
activ
measur
express
prematur
infant
advers
outcom
bpd
necrot
enterocol
periventricular
leukomalacia
cell
lower
gestat
age
also
shown
enhanc
cytokin
product
vitro
stimul
suggest
enhanc
express
preterm
accompani
induc
effector
function
may
contribut
sever
lung
diseas
report
regulatori
cell
hi
significantli
reduc
cord
blood
preterm
infant
develop
bpd
rais
potenti
enhanc
inflamm
due
reduc
inhibitori
control
suggest
rel
activ
cell
phenotyp
earli
gestat
age
reminisc
recoveri
bone
marrow
ablat
adult
repres
rapid
homeostat
expans
lymphopen
host
intraamniot
administr
rhesu
monkey
gestat
result
reduct
frequenc
treg
cell
lymphoid
organ
produc
cell
increas
potenti
link
utero
innat
immun
activ
inflammatori
lymphocytemedi
injuri
insight
potenti
cell
immunopatholog
bpd
may
gain
anim
adult
model
inflammatori
lung
diseas
baboon
model
bpd
thymic
involut
increas
peripher
cell
carri
marker
matur
robust
nonspecif
cytokin
secret
increas
autoreact
cell
lung
interstitium
associ
increas
bombesinlik
peptid
blp
treatment
neutral
antibodi
blp
correct
thymic
lung
patholog
seen
preterm
baboon
treat
oxygen
blp
also
elev
preterm
human
infant
bpd
suggest
mechan
link
lymphocyt
dysregul
bpd
degre
lung
immun
system
matur
time
infect
influenc
cytopathogen
respons
viru
perhap
bacteria
also
appear
set
trajectori
immun
respons
subsequ
challeng
newborn
mice
infect
rsv
compar
mice
infect
slightli
later
age
increas
bal
fluid
number
type
cell
fewer
cell
reinfect
adulthood
likewis
mice
infect
influenza
within
one
week
birth
show
enhanc
airway
hyperreact
chronic
pulmonari
inflamm
diffus
emphysematoustyp
lesion
adult
adapt
immun
insuffici
appar
neonat
cell
newborn
infect
associ
reduc
delay
respons
compar
infect
older
anim
rsv
infect
neonat
mice
recruit
cell
defect
product
associ
mild
symptom
reinfect
adult
howev
result
limit
viral
replic
enhanc
inflamm
cell
recruit
includ
cell
eosinophil
deplet
cell
cell
primari
neonat
infect
protect
adult
challeng
recal
respons
neonatalprim
adultprim
mice
associ
secret
indic
respons
howev
interleukin
secret
enhanc
neonatalprim
mice
rechalleng
mice
prime
newborn
also
associ
increas
concentr
monocyt
chemoattract
macrophag
inflammatori
rant
lung
suggest
neonat
cell
particular
cell
play
crucial
role
regul
immun
respons
neonat
infect
neonat
anim
model
adopt
transfer
naiv
cell
wildtyp
defici
donor
significantli
lower
pulmonari
viral
titer
greatli
improv
pulmonari
function
adult
support
import
secret
cell
determin
diseas
outcom
strong
argument
advanc
childhood
wheez
atopi
relat
reduc
cord
blood
studi
infant
predispos
asthma
atopi
less
robust
mitogenor
specif
antigeninduc
respons
cord
blood
cell
associ
wheez
episod
first
year
life
children
infect
rsv
rhinoviru
childhood
origin
asthma
coast
project
cytokinerespons
profil
cord
blood
mononuclear
cell
stimul
vitro
identifi
cord
blood
respons
invers
relat
frequenc
viral
respiratori
infect
wheez
infanc
enhanc
respons
one
year
correl
posit
frequenc
preced
viral
infect
sever
asthma
associ
excess
product
particularli
cell
potenti
reflect
cytotox
effect
cytokin
data
suggest
neonat
respons
influenc
subsequ
antivir
activ
convers
frequenc
viral
infect
infanc
influenc
respons
neutral
antibodi
provid
import
antivir
protect
infant
higher
rsv
neutral
antibodi
titer
prematur
term
infant
associ
protect
infect
lrti
effect
also
support
success
palvizumab
prevent
sever
rsv
diseas
prematur
infant
transplacent
transfer
matern
antibodi
invers
relat
length
gestat
preterm
infant
rel
less
humor
protect
contribut
diseas
risk
sinc
viral
load
rsv
hmpv
piv
rhinoviru
correl
sever
clinic
diseas
suggest
infant
greater
abil
control
viral
replic
upon
first
infect
via
presenc
neutral
antibodi
robust
respons
success
limit
excess
antigen
present
gener
protect
immun
respons
associ
viral
clearanc
avoid
immunopathogenesi
date
studi
evalu
antibodi
cellular
immun
phenotyp
togeth
viral
load
measur
infant
respiratori
infect
addit
associ
factor
diseas
sever
explor
prematur
infant
overal
alter
lymphocyterel
immun
occur
depend
gestat
age
matern
influenc
postnat
oxid
stress
viral
diseas
burgeon
data
area
prematur
infant
though
yet
minim
knowledg
specif
mechan
lymphocyt
particip
respiratori
outcom
prematur
infant
develop
bodi
research
suggest
acquisit
mainten
bacteri
popul
gut
soon
birth
import
driver
develop
system
mucos
immun
recent
advanc
highthroughput
sequenc
technolog
provid
insight
gut
microbiom
begin
describ
divers
dynam
microbi
popul
health
diseas
although
exact
factor
control
interact
gut
epitheli
cell
gut
associ
lymphoid
tissu
galt
gut
microbiom
yet
clear
three
compon
appear
play
signific
role
induct
immun
toler
lumin
bacteri
antigen
mainten
homeostasi
propos
mechan
identifi
anim
model
includ
block
innat
signal
via
receptor
develop
expans
fox
regulatori
cell
enhanc
product
gut
induc
commens
bacteria
presenc
specif
speci
bacteria
may
also
crucial
develop
gut
toler
suggest
rel
decreas
amount
bacteroid
bifidobact
lactobacillu
speci
patient
inflammatori
bowel
diseas
addit
time
acquisit
gut
bacteria
may
critic
posit
effect
health
neonat
defici
mice
expos
bacteri
antigen
delay
develop
coliti
week
age
compar
expos
decreas
product
explant
intestin
tissu
spleen
cell
follow
stimul
gut
bacteria
also
suggest
exposur
neonat
immun
system
antigen
microbiom
associ
mucos
system
immun
toler
find
may
especi
relev
preterm
infant
view
recent
data
show
invers
relationship
antibiot
therapi
parenter
nutrit
fecal
divers
infant
born
week
gestat
recent
studi
elderli
adult
also
suggest
improv
protect
influenza
infect
oral
provis
bifidobacterium
longum
speci
attent
recent
turn
determin
microbiom
respiratori
tract
prematur
infant
convent
theori
lower
airway
steril
challeng
identif
organ
deep
lung
adult
infant
children
initi
surprisingli
associ
diseas
cystic
fibrosi
chronic
obstruct
pulmonari
diseas
asthma
also
normal
microbiom
healthi
patient
preterm
infant
lohmann
etal
describ
nonsteril
tracheal
aspir
predomin
acinetobact
sampl
taken
intub
deliveri
room
persist
decreas
divers
organ
first
month
life
went
develop
bpd
earli
sustain
airway
bacteri
colon
infant
gram
birth
intub
least
week
detect
within
day
life
domin
staphylococcu
ureaplasma
ongo
studi
promis
longitudin
intestin
respiratori
microbiom
viral
infect
data
correl
respiratori
outcom
preterm
full
term
infant
clinicaltrialsgov
fund
respect
microb
bacteri
viru
fungi
other
flourish
human
skin
mucosa
affect
metabol
immun
system
health
diseas
host
becom
clear
effect
prematur
infant
affect
suscept
infect
alter
respiratori
outcom
import
area
current
research
